D
Blueprint Medicines Corporation BPMC
$87.11 -$2.90-3.22%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 86.77% 76.92% 62.92% 50.39% 9.06%
Total Depreciation and Amortization 39.66% -19.41% -19.30% -7.25% -0.60%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -177.41% -172.17% -183.68% -181.70% 2.39%
Change in Net Operating Assets -57.28% 23.68% 14.83% -126.33% 23.51%
Cash from Operations 55.91% 49.48% 34.03% 15.66% 13.03%
Capital Expenditure 71.17% 34.96% -41.06% -40.89% -80.09%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -114.78% -96.17% -192.23% 158.35% 306.30%
Cash from Investing -117.33% -101.72% -317.06% 177.25% 283.25%
Total Debt Issued 50.08% 50.00% 77.74% -28.92% -28.92%
Total Debt Repaid -1,129.55% -- -- -- --
Issuance of Common Stock 493.73% 1,508.53% 1,077.36% 1,179.11% 160.32%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 129.07% 162.63% -7.58% -66.78% -78.78%
Foreign Exchange rate Adjustments -550.00% 367.36% -164.79% -174.87% 197.58%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 174.03% 115.24% 83.14% -138.45% 51.91%
Weiss Ratings